A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia. Issue 11 (8th September 2020) - Pleyer, Christopher; Tian, Xin; Rampertaap, Shakuntala; Mu, Rui; Soto, Susan; Superata, Jeanine; Gaglione, Erika; Sun, Clare; Lotter, Jennifer; Stetler‐Stevenson, Maryalice; Yuan, Constance M.; Maric, Irina; et al.